GlobeImmune, Inc. (GBIM)

GlobeImmune Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011
Period Ending	Mar 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011
Net Income	-2.07	-2.77	-16.26	9.48	-2.01	-13.72
Depreciation & Amortization	0.13	0.19	0.3	0.77	0.93	0.95
Other Amortization	-	-	3.56	0.01	-	-
Loss (Gain) From Sale of Assets	-0.16	-0.16	-0.09	-	-	-
Stock-Based Compensation	0.12	0.15	0.05	0.21	0.37	0.36
Other Operating Activities	-	-	6.92	-1.84	-1.95	1.5
Change in Accounts Payable	-0.12	-0.34	-1.16	-0.83	1.64	0.18
Change in Unearned Revenue	-3.21	-3.21	-3.63	-3.14	-11.73	5.89
Change in Other Net Operating Assets	-0.6	-0.99	0.27	-0.72	-0.31	-0.17
Operating Cash Flow	-5.9	-7.13	-10.05	3.93	-13.07	-5.01
Capital Expenditures	-0.01	-0.04	-0.29	-0.01	-0.11	-0.13
Sale of Property, Plant & Equipment	0.25	0.25	0.13	-	-	-
Investing Cash Flow	0.24	0.22	-0.17	-0.01	-0.11	-0.13
Long-Term Debt Issued	-	-	7.5	-	-	-
Total Debt Issued	-	-	7.5	-	-	-
Net Debt Issued (Repaid)	-	-	7.5	-	-	-
Issuance of Common Stock	-	-	17.29	0	0.03	0
Other Financing Activities	-	-	-3.68	-	-	-
Financing Cash Flow	-	-	21.11	0	0.03	0
Net Cash Flow	-5.66	-6.91	10.89	3.92	-13.15	-5.14
Free Cash Flow	-5.92	-7.17	-10.35	3.92	-13.18	-5.14
Free Cash Flow Margin	-95.24%	-110.96%	-173.39%	17.41%	-90.00%	-100.59%
Free Cash Flow Per Share	-1.03	-1.25	-3.55	42.36	-147.43	-58.48
Levered Free Cash Flow	-1.65	-2.56	-3.8	3.83	-6.85	0.32
Unlevered Free Cash Flow	-1.65	-2.56	-4.93	3.82	-6.85	0.32
Change in Net Working Capital	0.59	1.14	1.34	1.95	5.56	-7.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.